Olanzapine, weight change and metabolic effects: a naturalistic 12-month follow up

Objective: Olanzapine is an atypical antipsychotic drug used to treat schizophrenia. Some of the adverse effects related to its use are obesity, hyperlipidemia, type 2 diabetes and hypertension, which may result in development of metabolic syndrome. This study aimed to investigate a possible increas...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Therapeutic advances in psychopharmacology 2014-02, Vol.4 (1), p.30-36
Hauptverfasser:	Salviato Balbão, Marina, Cecílio Hallak, Jaime Eduardo, Arcoverde Nunes, Emerson, Homem de Mello, Mauricio, Triffoni-Melo, Andresa de Toledo, Ferreira, Flavia Isaura de Santi, Chaves, Cristiano, Durão, Ana Maria Sertori, Ramos, Adriana Pelegrino Pinho, de Souza Crippa, José Alexandre, Queiroz, Regina Helena Costa
Format:	Artikel
Sprache:	eng
Schlagworte:	Original Research
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!